Syncona Limited (SYNC) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, Syncona Limited (SYNC) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX5.88 Million ≈ $715.18 USD) by net assets (GBX1.02 Billion ≈ $124.22K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Syncona Limited (SYNC) net asset quality to measure how much of total assets are equity-financed.

Syncona Limited - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Syncona Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Syncona Limited (SYNC) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Syncona Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Syncona Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Schroders Investment Trusts - Schroder Asian Total Return Investment Company plc
LSE:ATR
0.000x
YKGI Holdings Bhd
KLSE:7020
0.164x
paragon GmbH & Co. KGaA
F:PGN
0.013x
XOX Bhd
KLSE:0165
0.194x
UNITEDLABELS Aktiengesellschaft
F:ULC
0.048x
Lite Access Technologies Inc
V:LTE
1.235x
Dovre Group Plc
HE:DOV1V
-0.559x
Phoenix New Media Limited
NYSE:FENG
-0.002x

Annual Cash Flow Conversion Efficiency for Syncona Limited (2013–2025)

The table below shows the annual cash flow conversion efficiency of Syncona Limited from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Syncona Limited stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 GBX1.05 Billion
≈ $128.13K
GBX43.91 Million
≈ $5.34K
0.042x +152.35%
2024-03-31 GBX1.24 Billion
≈ $150.74K
GBX20.47 Million
≈ $2.49K
0.017x +7924.05%
2023-03-31 GBX1.25 Billion
≈ $152.66K
GBX-265.00K
≈ $-32.24
0.000x -205.59%
2022-03-31 GBX1.31 Billion
≈ $159.37K
GBX262.00K
≈ $31.88
0.000x +8769.65%
2021-03-31 GBX1.30 Billion
≈ $158.21K
GBX-3.00K
≈ $-0.37
0.000x -100.02%
2020-03-31 GBX1.25 Billion
≈ $151.67K
GBX13.17 Million
≈ $1.60K
0.011x +5025.32%
2019-03-31 GBX1.46 Billion
≈ $177.05K
GBX300.00K
≈ $36.50
0.000x -97.34%
2018-03-31 GBX1.06 Billion
≈ $128.46K
GBX8.19 Million
≈ $996.85
0.008x -2.37%
2017-03-31 GBX895.24 Million
≈ $108.92K
GBX7.12 Million
≈ $865.81
0.008x -35.69%
2016-03-31 GBX472.25 Million
≈ $57.46K
GBX5.84 Million
≈ $710.19
0.012x +9.43%
2015-03-31 GBX479.06 Million
≈ $58.29K
GBX5.41 Million
≈ $658.36
0.011x +10.87%
2014-03-31 GBX434.85 Million
≈ $52.91K
GBX4.43 Million
≈ $539.00
0.010x +469.18%
2013-03-31 GBX229.61 Million
≈ $27.94K
GBX-633.60K
≈ $-77.09
-0.003x --

About Syncona Limited

LSE:SYNC UK Asset Management
Market Cap
$7.90 Million
GBX64.96 Billion GBX
Market Cap Rank
#27608 Global
#394 in UK
Share Price
GBX106.80
Change (1 day)
+0.38%
52-Week Range
GBX86.90 - GBX109.80
All Time High
GBX302.47
About

Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and… Read more